Consensus Becton, Dickinson and Company Boerse Muenchen

Stocks

BOX

US0758871091

Medical Equipment, Supplies & Distribution

Market Closed - Boerse Muenchen 16:43:13 2026-08-13 EDT			5-day change	1st Jan Change
157.70 ^EUR	-0.87%		+7.81%	+20.86%

08-13	Becton, Dickinson's Consistent Mid-Single-Digit Organic Growth is 12-18 Months Away, RBC Says	MT
08-13	Citigroup Adjusts Price Target on Becton Dickinson and Co. to $208 From $204, Maintains Buy Rating	MT

Evolution of the Average Target: Becton, Dickinson and Company

Evolution of the Target Price: Becton, Dickinson and Company

Changes in Analyst Recommendations: Becton, Dickinson and Company

f3f235b2647767ca54bceca472402f.ff5TCqST-4eBjnQY8XClvLqfD7Tg7qeR-7Lr6xuX7Z4.MK0bfdTGyLLS3htHgxyQy4vyXdjZodPmntq4xiviof8MhGpjkNCX3973RA~b2a03b74df8b827b21cb5b0a539e2cef

Analysts' recommendations: Becton, Dickinson and Company

08-13	Becton, Dickinson's Consistent Mid-Single-Digit Organic Growth is 12-18 Months Away, RBC Says	MT
08-13	Citigroup Adjusts Price Target on Becton Dickinson and Co. to $208 From $204, Maintains Buy Rating	MT
08-13	RBC Adjusts PT on Becton Dickinson and Co. to $190 From $180, Keeps Sector Perform Rating	MT
08-12	UBS Adjusts Becton Dickinson and Co. PT to $205 From $190, Maintains Buy Rating	MT
08-07	Wells Fargo Adjusts Price Target on Becton Dickinson and Co. to $170 From $161	MT
08-07	Jefferies Adjusts Price Target on Becton Dickinson and Co. to $210 From $190	MT
08-07	Citigroup Adjusts Price Target on Becton Dickinson and Co. to $204 From $198	MT
08-07	Piper Sandler Adjusts Price Target on Becton Dickinson and Co. to $175 From $161	MT
08-07	JPMorgan Adjusts Price Target on Becton Dickinson and Co. to $188 From $175	MT
08-07	RBC Adjusts PT on Becton Dickinson and Co. to $180 From $175, Maintains Sector Perform Rating	MT
08-05	TD Cowen Adjusts Price Target on Becton, Dickinson and Company to $182 From $163	MT
07-28	UBS Initiates Coverage on Becton, Dickinson and Company With Buy Rating, $190 Price Target	MT
07-14	Goldman Sachs Adjusts Price Target on Becton, Dickinson and Company to $152 From $150, Maintains Neutral Rating	MT
07-09	Waters Seen Benefiting From BD Turnaround, Pharma Manufacturing Tailwinds, RBC Says	MT
07-06	Evercore ISI Adjusts Price Target on Becton, Dickinson and Company to $180 From $190	MT
06-12	BofA Adjusts Price Target on Becton, Dickinson and Company to $170 From $177	MT
05-27	Goldman Sachs Adjusts PT on Becton, Dickinson and Co. to $150 From $156, Maintains Neutral Rating	MT
05-08	Becton, Dickinson Building Growth After 'Clean' Fiscal Q2 Beat, RBC Says	MT
05-07	Evercore ISI Adjusts Price Target on Becton, Dickinson and Company to $190 From $180	MT
05-07	Stifel Nicolaus Adjusts Becton, Dickinson and Company Price Target to $175 From $215	MT
05-04	TD Cowen Adjusts Price Target on Becton, Dickinson and Company to $163 From $189, Maintains Hold Rating	MT
05-04	U.S. research roundup - Alphabet, Colgate-Palmolive, Welltower	RE
04-17	Piper Sandler Adjusts Becton, Dickinson and Company PT to $159 From $170, Maintains Neutral Rating	MT
04-14	RBC Cuts Price Target on Becton, Dickinson to $175 From $195, Keeps Sector Perform Rating	MT
03-23	Argus Research Adjusts Becton, Dickinson and Company Price Target to $180 From $230, Maintains Buy Rating	MT

More recommendations

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ABBOTT LABORATORIES					+6.77%
	MEDTRONIC PLC					+8.46%
	CENCORA, INC.					+18.59%
	HOYA CORPORATION					+17.26%
	BECTON, DICKINSON AND COMPANY					+5.27%
	DEXCOM, INC.					+2.91%
	MEDLINE INC.					+25.68%
	WEST PHARMACEUTICAL SERVICES, INC.					+14.89%
	TERUMO CORPORATION					+18.35%
	Average					+13.13%
	Weighted average by Cap.					+10.76%

See all sector consensus

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

181.97USD

Average target price

194.42USD

Spread / Average Target

+6.84%

High Price Target

225.00USD

Spread / Highest target

+23.65%

Low Price Target

170.00USD

Spread / Lowest Target

-6.58%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

UBS
Wells Fargo Securities
Jefferies & Co.
Citigroup
Piper Sandler
JPMorgan Chase
RBC Capital Markets
TD Cowen
Goldman Sachs
Evercore ISI
BofA Securities
Stifel Nicolaus
Argus
Morgan Stanley
Barclays
Raymond James
William Blair & Co.
DBS Bank
KeyBanc Capital Markets
Baird
SVB Leerink